Effects of vitamins E and C combined with β carotene on cognitive function in the elderly

Experimental and Therapeutic Medicine

Volumn 9, Issue 4, 2015, Pages 1489-1493

  Li, Yonghua ^a   Liu, Shumei ^b   Man, Yigang ^b   Li, Ning ^a   Zhou, Yu ^a  

^a JINING MEDICAL UNIVERSITY   (China)

^b JINING NO 1 PEOPLE S HOSPITAL   (China)

Author keywords

Amyloid ; Elderly cognitive function; Estradiol; Vitamin C; Vitamin E; carotene

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; ASCORBIC ACID; BETA CAROTENE; ESTRADIOL;

ADULT; AGED; ARTICLE; CHRONIC BRONCHITIS; COGNITION; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; FEMALE; HASEGAWA DEMENTIA SCALE; HUMAN; HYPERTENSION; LEARNING; MALE; MEMORY; MENTAL DISEASE ASSESSMENT; MINI MENTAL STATE EXAMINATION; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; STOMACH DISEASE; VITAMIN SUPPLEMENTATION;

EID: 84923011928     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2274     Document Type: Article

References (32)

1. Schneider N and Yvon C: A review of multidomain interventions to support healthy cognitive ageing. J Nutr Health Aging 17: 252-257, 2013.
2. De Paula VJ, Radanovic M, Diniz BS and Forlenza OV: Alzheimer's disease. Subcell Biochem 65: 329-352, 2012.
3. Grundman M, Petersen RC, Ferris SH, et al; Alzheimer's Disease Cooperative Study: Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 61: 59-66, 2004.
4. Chico L, Simoncini C, Lo Gerfo A, et al: Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment. Free Radic Res 47: 569-576, 2013.
5. Izco M, Martínez P, Corrales A, et al: Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Neuroscience 263: 269-279, 2014.
6. Kosenko EA, Solomadin IN, Tikhonova LA, Reddy VP, Aliev G and Kaminsky YG: Pathogenesis of Alzheimer disease: role of oxidative stress, amyloid β peptides, systemic ammonia and erythrocyte energy metabolism. CNS Neurol Disord Drug Targets 13: 112-119, 2014.
7. Peacock JM, Folsom AR, Knopman DS, Mosley TH, Goff DC Jr and Szklo M: Dietary antioxidant intake and cognitive performance in middle aged adults. The Atherosclerosis Risk in Communities (ARIC) Study investigators. Public Health Nutr 3: 337-343, 2000.
8. Harrison FE: A critical review of vitamin C for the prevention of age related cognitive decline and Alzheimer's disease. J Alzheimers Dis 29: 711-726, 2012.
9. Grodstein F, O'Brien J, Kang JH, Dushkes R, Cook NR, Okereke O, Manson JE, Glynn RJ, Buring JE, Gaziano M and Sesso HD: Long term multivitamin supplementation and cognitive function in men: a randomized trial. Ann Intern Med 159: 806-814, 2013.
10. Ristow M: Unraveling the truth about antioxidants: mitohormesis explains ROS induced health benefits. Nat Med 20: 709-711, 2014.
11. Yakushiji Y, Horikawa E, Eriguchi M, Nanri Y, Nishihara M, Hirotsu T and Hara H: Norms of the Mini Mental state Examination for Japanese subjects that underwent comprehensive brian examinations: the Kashima Scan Study. Intern Med 53: 2447-2453, 2014.
12. Jeong JW, Kim KW, Lee DY, Lee SB, Park JH, Choi EA, Choe JY, Do YJ, Ryang JS, Roh HA, Park YS, Choi Y and Woo JI: A normative study of the Revised Hasegawa Dementia Scale: comparison of demographic influences between the Revised Hasegawa Dementia Scale and the Mini Mental Status Examination. Dement Geriatr Cogn Disord 24: 288-293, 2007.
13. Krishnan S and Rani P: Evaluation of selenium, redox status and their association with plasma amyloid/tau in Alzheimer's disease. Biol Trace Elem Res 158: 158-165, 2014.
14. Hruska Z and Dohanich GP: The effects of chronic estradiol treatment on working memory deficits induced by combined infusion of beta amyloid (1 42) and ibotenic acid. Horm Behav 52: 297-306, 2007.
15. Kolosova NG, Shcheglova TV, Sergeeva SV and Loskutova LV: Long term antioxidant supplementation attenuates oxidative stress markers and cognitive deficits in senescent accelerated OXYS rats. Neurobiol Aging 27: 1289-1297, 2006.
16. Karpińska A and Gromadzka G: Oxidative stress and natural antioxidant mechanisms: the role in neurodegeneration. From molecular mechanisms to therapeutic strategies. Postepy Hig Med Dosw (Online) 67: 43-53, 2013 (In Polish).
17. Jomova K, Vondrakova D, Lawson M and Valko M: Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 345: 91-104, 2010.
18. Joshi YB and Praticò D: Vitamin E in aging, dementia and Alzheimer's disease. Biofactors 38: 90-97, 2012.
19. Boyd Kimball D, Sultana R, Mohmmad Abdul H and Butterfield DA: Rodent Abeta(1 42) exhibits oxidative stress properties similar to those of human Abeta(1 42): Implications for proposed mechanisms of toxicity. J Alzheimers Dis 6: 515-525, 2004.
20. Sen Gupta R, Sen Gupta E, Dhakal BK, Thakur AR and Ahnn J: Vitamin C and vitamin E protect the rat testes from cadmium induced reactive oxygen species. Mol Cells 17: 132-139, 2004.
21. Zhang Y, Li Q, Liu X, Zhu H, Song A and Jiao J: Antioxidant and micronutrient rich milk formula reduces lead poisoning and related oxidative damage in lead exposed mice. Food Chem Toxicol 57: 201-208, 2013.
22. Karajibani M, Hashemi M, Montazerifar F and Dikshit M: Effect of vitamin E and C supplements on antioxidant defense system in cardiovascular disease patients in Zahedan, southeast Iran. J Nutr Sci Vitaminol (Tokyo) 56: 436-440, 2010.
23. Martin A: Antioxidant vitamins E and C and risk of Alzheimer's disease. Nutr Rev 61: 69-73, 2013.
24. Grodstein F, Chen J and Willett WC: High dose antioxidant supplements and cognitive function in community dwelling elderly women. Am J Clin Nutr 77: 975-984, 2003.
25. Ogunniyi A, Baiyewu O, Gureje O, et al: Epidemiology of dementia in Nigeria: results from the Indianapolis Ibadan study. Eur J Neurol 7: 485-490, 2000.
26. Martin A, Youdim K, Szprengiel A, Shukitt Hale B and Joseph J: Roles of vitamins E and C on neurodegenerative diseases and cognitive performance. Nutr Rev 60: 308-326, 2002.
27. Trushina E and Mielke MM: Recent advances in the application of metabolomics to Alzheimer's Disease. Biochim Biophys Acta 1842: 1232-1239, 2014.
28. Swomley AM, Förster S, Keeney JT, Triplett J, Zhang Z, Sultana R and Butterfield DA: Abeta, oxidative stress in Alzheimer disease: Evidence based on proteomics studies. Biochim Biophys Acta 1842: 1248-1257, 2014.
29. Zhao Y and Zhao B: Oxidative stress and the pathogenesis of Alzheimer's disease. Oxid Med Cell Longev 2013: 316523, 2013.
30. Kocoska Maras L, Rådestad AF, Carlström K, Bäckström T, von Schoultz B and Hirschberg AL: Cognitive function in association with sex hormones in postmenopausal women. Gynecol Endocrinol 29: 59-62, 2013.
31. Rodgers SP, Bohacek J and Daniel JM: Transient estradiol exposure during middle age in ovariectomized rats exerts lasting effects on cognitive function and the hippocampus. Endocrinology 151: 1194-1203, 2010.
32. Glinskii OV, Huxley VH, Glinskii VV, Rubin LJ and Glinsky VV: Pulsed estrogen therapy prevents post OVX porcine dura mater microvascular network weakening via a PDGF BB dependent mechanism. PLoS One 8: e82900, 2013.